Miravant Medical Technologies Inc.
MRVT · OTC
9/30/2005 | 6/30/2005 | 3/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2,050 | $3,275 | $1,852 | $1,868 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $964 | $1,148 | $1,450 | $960 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,014 | $4,423 | $3,302 | $2,828 |
| Operating Income | $3,014 | $4,423 | $3,302 | $2,828 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$3,014 | -$4,423 | -$3,302 | -$2,828 |
| Pre-Tax Income | $3,015 | $4,427 | $3,330 | $2,830 |
| Tax Expense | $471 | $462 | $408 | $428 |
| Net Income | -$3,485 | -$4,885 | -$3,710 | -$3,256 |
| % Margin | – | – | – | – |
| EPS | -0.093 | -0.13 | -0.1 | -0.09 |
| % Growth | 28.5% | -30% | -11.6% | – |
| EPS Diluted | -0.093 | -0.13 | -0.1 | -0.09 |
| Weighted Avg Shares Out | 37,512 | 37,255 | 36,939 | 36,346 |
| Weighted Avg Shares Out Dil | 37,512 | 37,255 | 36,939 | 36,346 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $84 | $47 | $50 | $52 |
| EBITDA | -$2,930 | -$4,376 | -$3,252 | -$2,776 |
| % Margin | – | – | – | – |